Roivant Sciences
ROIV
ROIV
395 hedge funds and large institutions have $11B invested in Roivant Sciences in 2025 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 149 increasing their positions, 95 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 337 → 395 (+58)
0.3% less ownership
Funds ownership: 73.45% → 73.15% (-0.3%)
7% less funds holding in top 10
Funds holding in top 10: 15 → 14 (-1)
Holders
395
Holding in Top 10
14
Calls
$166M
Puts
$50.8M
Top Buyers
| 1 | +$309M | |
| 2 | +$277M | |
| 3 | +$170M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$136M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$98.9M |
Top Sellers
| 1 | -$472M | |
| 2 | -$338M | |
| 3 | -$217M | |
| 4 |
PSC
Patient Square Capital
Menlo Park,
California
|
-$85.1M |
| 5 |
SC
Stempoint Capital
New York
|
-$63.7M |
